Loading company…
Shanghai Medicilon provides outsourced research and development services for pharmaceutical companies.
Founded in 2004, Shanghai Medicilon is based in Shanghai, China, with branch offices in Hangzhou and America. It provides pharmaceutical R&D outsourcing, including compound synthesis and screening, structural biology, pharmacodynamic and pharmacokinetic studies, and toxicology evaluation. Founder and CEO Chunlin Chen is a member of the Pharmacokinetics Committee of the Chinese Pharmacological Society. The company listed on the Shanghai Stock Exchange in November 2019.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in